R&D Efforts for Better Detection and Diagnosis of Influenza Drives the Influenza Diagnostics Industry by 2031

The global influenza diagnostics market was valued at USD 0.9 billion in 2021 and it is anticipated to grow further till USD 1.6 billion by 2031, at a CAGR of 5.9% during the forecast period.

Download Free Sample of Report - https://www.globalinsightservices.com/request-sample/GIS10306

The influenza virus is the infectious disease that causes influenza, also referred to as "the flu." Flu is identified and diagnosed using a variety of conventional and molecular diagnostic tools. Modern technology is able to diagnose influenza quite effectively and precisely. For instance, the real-time molecular test known as the reverse transcription-polymerase chain reaction (RT-PCR) allows for the identification of influenza genetic material. Furthermore, due of its quick results and simple specimen collection, rapid influenza diagnostic testing (RIDT) has become an efficient approach for diagnosis.

Read more about Influenza Diagnostics Market here: https://www.globalinsightservices.com/reports/influenza-diagnostics-market

Market Trends and Drivers

R&D efforts for better detection and diagnosis of influenza have intensified due to its rising frequency globally. The majority of research efforts concentrate on creating quicker and more precise diagnostic tools for influenza viruses, which will spur market expansion. Similarly, Numerous assays and technologies helpful for the diagnosis and treatment of influenza infections have been developed as a result of the enormous quantity of data produced by the Human Genome Project and developments in molecular and biomedical technologies. These new genomic and proteomic technologies, such as microarray-based detection and PCR-based approaches, aid in the identification of novel influenza viruses. Additionally, they allow for quicker and better surveillance of infectious diseases, which presents a business opportunity.

Get Customized Report as Per Your Requirement - https://www.globalinsightservices.com/request-customization/GIS10306

Global Influenza Diagnostics Market Segmentation

By Product

Test Kit and Reagent
Instruments
Other Products

By Test Type

Molecular Diagnostic Tests
Traditional Diagnostic Test

By End User

Diagnostic Laboratories
Hospitals & Clinics
Other End Users

Major Players in the Global Influenza Diagnostics Market

The key players in the market are Danaher Corporation (US), Siemens Healthineers (Germany), Thermo Fisher Scientific, Inc. (US), F. Hoffmann-LA Roche AG (Switzerland), Abbott Laboratories, Inc. (US), Hologic, Inc. (US), bioMérieux SA (France), Quidel Corporation (US), Becton, Dickinson and Company (US), Meridian Bioscience (US), GenMark Diagnostics, Inc. (US), Luminex Corporation (US), Tecan Trading AG (Switzerland), DiaSorin SA (Italy), and altona Diagnostics GmbH (Germany) among others.

Purchase This Market Research Report - https://www.globalinsightservices.com/checkout/single_user/GIS10306

With Global Insight Services, you receive:

10-year forecast to help you make strategic decisions
In-depth segmentation which can be customized as per your requirements
Free consultation with lead analyst of the report
Excel data pack included with all report purchases
Robust and transparent research methodology

Groundbreaking research and market player-centric solutions for the upcoming decade according to the present market scenario

Contact Us:

Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700
Website: https://www.globalinsightservices.com/

About Global Insight Services:

Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with the highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.

This release was published on openPR.